Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2019 / Article

Corrigendum | Open Access

Volume 2019 |Article ID 1536397 | https://doi.org/10.1155/2019/1536397

Wen-Rui Hao, Li-Chin Sung, Chun-Chao Chen, Po-Yuan Chen, Tzu-Hurng Cheng, Hung-Hsing Chao, Ju-Chi Liu, Jin-Jer Chen, "Corrigendum to “Cafestol Inhibits Cyclic-Strain-Induced Interleukin-8, Intercellular Adhesion Molecule-1, and Monocyte Chemoattractant Protein-1 Production in Vascular Endothelial Cells”", Oxidative Medicine and Cellular Longevity, vol. 2019, Article ID 1536397, 1 page, 2019. https://doi.org/10.1155/2019/1536397

Corrigendum to “Cafestol Inhibits Cyclic-Strain-Induced Interleukin-8, Intercellular Adhesion Molecule-1, and Monocyte Chemoattractant Protein-1 Production in Vascular Endothelial Cells”

Received15 Apr 2019
Accepted16 Apr 2019
Published04 Jul 2019

In the article titled “Cafestol Inhibits Cyclic-Strain-Induced Interleukin-8, Intercellular Adhesion Molecule-1, and Monocyte Chemoattractant Protein-1 Production in Vascular Endothelial Cells” [1], there were errors in the first and second affiliations. The corrected affiliations’ list is shown above.

References

  1. W.-R. Hao, L.-C. Sung, C.-C. Chen et al., “Cafestol inhibits cyclic-strain-induced interleukin-8, intercellular adhesion molecule-1, and monocyte chemoattractant protein-1 production in vascular endothelial cells,” Oxidative Medicine and Cellular Longevity, vol. 2018, Article ID 7861518, 10 pages, 2018. View at: Publisher Site | Google Scholar

Copyright © 2019 Wen-Rui Hao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views599
Downloads283
Citations

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.